STRATA Skin Sciences Inc (SSKN)
Official siteMEDICAL DEVICES
Last updated: Nov 13, 2026 at 4:00 PM ET
Earnings
Performance (10Y)
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 94.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.8, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about SSKN
News
No news available
Company news will appear here when available
SSKN Valuation
- P/FCF
- -0.0x
- P/B
- 0.0x
SSKN Profitability: Margins, ROIC and FCF
STRATA Skin Sciences (SSKN) has a gross margin of 58.3%. It posts -20.3% ROIC and a -14.3% FCF margin.
- Gross margin
- 58.3%
- ROIC
- -20.3%
- FCF margin
- -14.3%
- FCF yield
- -744540.1%
STRATA Skin Sciences Competitors
Peers by sector and size for STRATA Skin Sciences (SSKN) include Jasper Therapeutics, DIH Holdings US, Inc. Class A Common Stock and Protagenic Therapeutics.
Sector: Healthcare
SSKN Bull Case vs Bear Case
Bear case
- SSKN beat EPS estimates in 37.5% of its last 8 reported quarters.
- SSKN has a debt-to-equity ratio of 5.3x.
SSKN Earnings: Beat Rate
The next report from STRATA Skin Sciences (SSKN) is expected on Mar 24, 2027.
- Beat rate
- 3 of 8 quarters (37.5%)
- Average surprise
- -30.3%
SSKN Earnings Date
SSKN reports Mar 24, 2027. The date is estimated.
SSKN Earnings Call
The latest SSKN earnings call transcript on file is labeled 2025Q3.
Read the 2025Q3 transcriptUpdated Mar 31, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About SSKN
When does SSKN report earnings?
STRATA Skin Sciences Inc (SSKN) is expected to report earnings on Mar 24, 2027.
Does SSKN pay dividends?
STRATA Skin Sciences Inc (SSKN) does not currently pay a regular dividend.
SSKN pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.